Pliant Therapeutics (PLRX) Preferred Dividend Payments (2019 - 2020)
Pliant Therapeutics (PLRX) reported Preferred Dividend Payments of $11.0 million for Q1 2020, up 207.05% quarter-over-quarter from -$10.3 million in Q4 2019.
Pliant Therapeutics (PLRX) Preferred Dividend Payments (2019 - 2020) Analysis & Trends
Pliant Therapeutics (PLRX) has 2 years of Preferred Dividend Payments data on file, last reported at $11.0 million in Q1 2020.
- Preferred Dividend Payments for Q1 2020 came in at $11.0 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2021 was $2.1 million (down 39.28% YoY), and the FY2019 annual result was -$6.2 million, changed N/A from the prior year.
- Preferred Dividend Payments climbed to $11.0 million in Q1 2020 per PLRX's latest filing, from -$10.3 million in the prior quarter.
- Over five years, Preferred Dividend Payments peaked at $11.0 million in Q1 2020 and troughed at -$10.3 million in Q4 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | - |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | - |
| 10 | Pliant Therapeutics | 74.16 Mn | 74.16 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2020 | 11.03 Mn |
| Dec 31, 2019 | -10.30 Mn |
| Sep 30, 2019 | 1.38 Mn |
| Jun 30, 2019 | 1.36 Mn |